Relevance of the U.S. Dyslipidemia Guideline to Low- and Middle-Income Countries
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration
This publication has 16 references indexed in Scilit:
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of DyslipidemiaJACC, 2026
- Lessons Learned From Treating 34 Million People With HypertensionJACC, 2025
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023JACC, 2025
- Social factors, health policy, and environment: implications for cardiovascular disease across the globeEuropean Heart Journal, 2025
- Pitavastatin to Prevent Cardiovascular Disease in HIV InfectionNew England Journal of Medicine, 2023
- Diagnostic testing for hypertension, diabetes, and hypercholesterolaemia in low-income and middle-income countries: a cross-sectional study of data for 994 185 individuals from 57 nationally representative surveysThe Lancet Global Health, 2023
- Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income CountriesJACC, 2023
- Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level dataThe Lancet Global Health, 2022
- Repositioning of the global epicentre of non-optimal cholesterolNature, 2020
- Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysisThe Lancet Global Health, 2018